Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Anxiolytic   Midazolam hydrochloride  
Injection
Capsule Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Benzosed Ecuador, India, Venezuela
Buccolam Belgium, Germany
Crismidor Colombia
Dalam Argentina
Dormicum Argentina, Austria, Belgium, Colombia, Croatia, Denmark, Egypt, Finland, Germany, Greece, Hungary, Ireland, Mexico, Netherlands, Poland, Portugal, Republic of South Africa, Romania, Russian, Saudi Arabia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Arab Emirates
Dormipron Colombia
Dormire Brazil, Chile
Dormomid Brazil, Chile
Gobbizolam Argentina
Hipnazolam Brazil
Hypnovel Australia, France, Great Britain, Morocco, New Zealand
Induson Brazil, Colombia
Lamcord Mexico
Midanium Poland
Midasedan Colombia
Midaselect Germany
Midozor Mexico
Relacum Brazil, Colombia, Ecuador, Mexico
Sedoz Colombia
Somnocal Mexico
Sopodorm Poland
Zolamid Portugal, Turkey
Zolmid Chile
Stability in solutions   Injection   Stability in solutions : Midazolam hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0,03 mg/ml 4°C Protect from light
72 Hour
896

Glass NaCl 0,9% or Glucose 5% 0,5 mg/ml 24-26°C Protect from light
36 Day
41
Level of evidence A
Glass NaCl 0,9% or Glucose 5% 0,5 mg/ml 39-41°C Protect from light
36 Day
41
Level of evidence A
Glass NaCl 0,9% or Glucose 5% 0,5 mg/ml 4-6°C Protect from light
36 Day
41
Level of evidence A
Glass Sodium chloride 0,9% 0,036 mg/ml 21°C Protect from light
24 Hour
350

Glass Glucose 5% 0,5 mg/ml -20°C Protect from light
14 Day
2376

Glass Glucose 5% 0,5 mg/ml 21-25°C With or without light
14 Day
2376

Glass Glucose 5% 0,5 mg/ml 7-9°C Protect from light
14 Day
2376

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,03 mg/ml 4°C Protect from light
72 Hour
896

Polyvinyl chloride Sodium chloride 0,9% 0,036 mg/ml 21°C Protect from light
24 Hour
350

Polyvinyl chloride Sodium chloride 0,9% 1 mg/ml 20°C-25°C With or without light
30 Day
399
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 1 mg/ml 22°C-24°C With or without light
10 Day
185
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 1 mg/ml 4°C Protect from light
30 Day
399
Level of evidence D
Polyvinyl chloride Glucose 5% 1 mg/ml 20-25°C With or without light
27 Day
3222
Level of evidence B
Polyvinyl chloride Glucose 5% 1 mg/ml 3-4°C Protect from light
27 Day
3222
Level of evidence B
Polyethylene NaCl 0,9% or Glucose 5% 0,035 mg/ml 22°C Protect from light
24 Hour
1067
Level of evidence C
Polyethylene NaCl 0,9% or Glucose 5% 0,035 mg/ml 4°C Protect from light
24 Hour
1067
Level of evidence C
Polyethylene Sodium chloride 0,9% 0,036 mg/ml 21°C Protect from light
24 Hour
350

Polyolefine NaCl 0,9% or Glucose 5% 0,5 mg/ml 2-6°C Protect from light
30 Day
231
Level of evidence A
Polyolefine NaCl 0,9% or Glucose 5% 0,5 mg/ml 22°C-24°C Protect from light
30 Day
231
Level of evidence A
Polyolefine Glucose 5% 1 mg/ml 20-25°C With or without light
27 Day
3222
Level of evidence B
Polyolefine Glucose 5% 1 mg/ml 3-4°C Protect from light
27 Day
3222
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml -20°C Protect from light
365 Day
3989
Level of evidence C
Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml -20°C Not specified
365 Day
4201
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml 2-8°C Not specified
365 Day
4201
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml 23-25°C Not specified
90 Day
4201
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 1 mg/ml 5°C Protect from light
365 Day
3989
Level of evidence C
Polypropylen Syringe Sodium chloride 0,9% 2 mg/ml 30°C Not specified
10 Day
5
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 2 mg/ml 5°C Not specified
10 Day
5
Level of evidence B
Polypropylen Syringe Sodium chloride 0,9% 3 mg/ml 20°C Light
7 Day
401
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 3 mg/ml 32°C Not specified
7 Day
401
Level of evidence D
Polypropylen Syringe Glucose 5% 0,4 mg/ml 25°C Not specified
100 Day
4303
Level of evidence A
Polypropylen Syringe None 5 mg/ml 24-26°C Protect from light
36 Day
41
Level of evidence A
Polypropylen Syringe None 5 mg/ml 25°C Not specified
100 Day
4303
Level of evidence A
AT-Closed vial® Sodium chloride 0,9% 1 mg/ml -20°C Protect from light
365 Day
3989
Level of evidence C
AT-Closed vial® Sodium chloride 0,9% 1 mg/ml -20°C Not specified
365 Day
4201
Level of evidence A+
AT-Closed vial® Sodium chloride 0,9% 1 mg/ml 2-8°C Not specified
365 Day
4201
Level of evidence A+
AT-Closed vial® Sodium chloride 0,9% 1 mg/ml 23-25°C Not specified
90 Day
4201
Level of evidence A+
AT-Closed vial® Sodium chloride 0,9% 1 mg/ml 5°C Protect from light
365 Day
3989
Level of evidence C
  Mentions Légales